J.W. Cole Advisors, Inc.

Source: SEC Form 13F · as of Mar 2026

J.W. Cole Advisors, Inc. holds 30 biotech & pharma companies tracked by BioSniper, totaling $72.8M in value as of Mar 2026 (SEC Form 13F).

Companies held

30

Total value held

$72.8M

CompanySharesValue
ABBVAbbVie Inc.74,738$16.3M
MRKMerck & Co., Inc.101,517$12.2M
AMGNAMGEN INC16,661$5.9M
UNHUnitedHealth Group Incorporated Common Stock (DE)20,318$5.5M
ABTABBOTT LABORATORIES46,080$4.7M
MCKMcKesson Corporation5,258$4.5M
SUNSUNSET ISLAND GROUP60,483$3.9M
IDXXIDEXX LABORATORIES INC /DE4,889$2.7M
GMOptec International, Inc.35,648$2.7M
CAHCardinal Health Inc.10,727$2.3M
AZNASTRAZENECA PLC10,930$2.2M
CORCencora Inc.6,696$2.1M
NVSNovartis AG10,778$1.6M
GEHCGE HealthCare Technologies Inc.13,327$949K
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)13,350$737K
VRTXVERTEX PHARMACEUTICALS INC / MA1,565$699K
REGNREGENERON PHARMACEUTICALS, INC.855$661K
ACADACADIA PHARMACEUTICALS INC20,632$459K
ELVElevance Health Inc.1,441$422K
SNYSanofi7,616$367K
ZTSZoetis Inc.2,881$341K
DGXQuest Diagnostics Incorporated1,514$297K
RVMDREVOLUTION MEDICINES, INC.2,709$263K
ZBHZimmer Biomet Holdings Inc.2,879$260K
VTRSViatris Inc17,907$242K
INCYIncyte Corp.2,210$208K
BAXBaxter International Inc.10,387$175K
ESPREsperion Therapeutics, Inc.31,415$86K
AKBAAkebia Therapeutics, Inc.11,937$17K
UPXIUPEXI, INC.15,100$15K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.

    J.W. Cole Advisors, Inc. — Biotech 13F Holdings & Portfolio | BioSniper